Cargando…

The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer

Overall survival for patients with ovarian cancer (OC) has shown little improvement for decades meaning new therapeutic options are critical. OC comprises multiple histological subtypes, of which the most common and aggressive subtype is high-grade serous ovarian cancer (HGSOC). HGSOC is characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Shunfei, Frank, Daniel, Son, Jinbae, Hannan, Katherine M., Hannan, Ross D., Chan, Keefe T., Pearson, Richard B., Sanij, Elaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297839/ https://www.ncbi.nlm.nih.gov/pubmed/28117679 http://dx.doi.org/10.3390/ijms18010210

Ejemplares similares

CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
por: Sanij, Elaine, et al.
Publicado: (2020)

The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer
por: Yan, Shunfei, et al.
Publicado: (2020)

Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis
por: Kusnadi, Eric P, et al.
Publicado: (2020)

Perturbations at the ribosomal genes loci are at the centre of cellular dysfunction and human disease
por: Diesch, Jeannine, et al.
Publicado: (2014)

rDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase I Transcription Inhibitor CX-5461
por: Son, Jinbae, et al.
Publicado: (2020)

Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
por: Kang, Jian, et al.
Publicado: (2021)

Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
por: Udugama, Maheshi, et al.
Publicado: (2018)

Genome wide mapping of UBF binding-sites in mouse and human cell lines
por: Diesch, Jeannine, et al.
Publicado: (2015)

UBF levels determine the number of active ribosomal RNA genes in mammals
por: Sanij, Elaine, et al.
Publicado: (2008)

Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer
por: Koc, Zeynep C., et al.
Publicado: (2023)

The Ribosomal Gene Loci—The Power behind the Throne
por: Panov, Konstantin I., et al.
Publicado: (2021)

c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation
por: Poortinga, Gretchen, et al.
Publicado: (2011)

A functional genetic screen defines the AKT-induced senescence signaling network
por: Chan, Keefe T., et al.
Publicado: (2019)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer
por: Hannan, Natalie J., et al.
Publicado: (2021)

Amino acid-dependent signaling via S6K1 and MYC is essential for regulation of rDNA transcription
por: Kang, Jian, et al.
Publicado: (2016)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Further Understanding of High-Grade Serous Ovarian Carcinogenesis: Potential Therapeutic Targets
por: Voutsadakis, Ioannis A
Publicado: (2020)

Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
por: Stur, Elaine, et al.
Publicado: (2022)

Autophagy Induction Is a Tor- and Tp53-Independent Cell Survival Response in a Zebrafish Model of Disrupted Ribosome Biogenesis
por: Boglev, Yeliz, et al.
Publicado: (2013)

Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation
por: Diesch, Jeannine, et al.
Publicado: (2019)

CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer
por: Xuan, Jiachen, et al.
Publicado: (2020)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

The emerging roles of ribosome biogenesis in craniofacial development
por: Ross, Adam P., et al.
Publicado: (2014)

Ribosome Biogenesis in Archaea
por: Londei, Paola, et al.
Publicado: (2021)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

Ribosome Biogenesis and Cancer: Overview on Ribosomal Proteins
por: Pecoraro, Annalisa, et al.
Publicado: (2021)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

Ribosome biogenesis in disease: new players and therapeutic targets
por: Jiao, Lijuan, et al.
Publicado: (2023)

ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells
por: Chen, Chi-Wei, et al.
Publicado: (2020)

Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers
por: Neal, Adam, et al.
Publicado: (2021)

Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
por: Bergsten, Tova M., et al.
Publicado: (2022)

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling
por: Quin, Jaclyn, et al.
Publicado: (2016)

9-Aminoacridine Inhibits Ribosome Biogenesis by Targeting Both Transcription and Processing of Ribosomal RNA
por: Anikin, Leonid, et al.
Publicado: (2022)

The Ribosome Biogenesis—Cancer Connection
por: Penzo, Marianna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7lotlkmh57jsepk5kglntu3dva